ID   Silvanus
AC   CVCL_QW70
SY   SILVANUS
DR   Wikidata; Q54953492
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7919343;
RX   PubMed=9444937;
CC   Doubling time: 2-3 days (PubMed=9444937).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=7919343; DOI=10.1182/blood.V84.7.2253.2253;
RA   Renard N., Duvert V., Banchereau J., Saeland S.;
RT   "Interleukin-13 inhibits the proliferation of normal and leukemic
RT   human B-cell precursors.";
RL   Blood 84:2253-2260(1994).
//
RX   PubMed=9444937; DOI=10.1016/S0145-2126(97)00099-4;
RA   Renard N., Harada N., Callet-Bauchu E., Miyajima A., Duvert V.,
RA   Banchereau J., Saeland S.;
RT   "Heterogeneity of the inhibitory effects of IL-4 in two novel B
RT   lineage acute lymphoblastic leukemia cell lines.";
RL   Leuk. Res. 21:1037-1046(1997).
//